##fileformat=VCFv4.1
##source=VarSeqV2.5.0
##fileDate=20230918
##INFO=<ID=Type,Number=1,Type=String,Description="Type of CNV event (either Gain, Loss, or CN LoH)">
##INFO=<ID=Targets,Number=1,Type=Integer,Description="Number of targets in this event">
##INFO=<ID=Samples2,Number=1,Type=Integer,Description="Number of samples that share this event">
##INFO=<ID=Span,Number=1,Type=Integer,Description="Size of this event">
##INFO=<ID=GeneNames,Number=.,Type=String,Description="The set of unique gene names seen in all overlapping transcripts">
##INFO=<ID=GeneIDs,Number=.,Type=String,Description="The set of Entrez gene identifiers for all overlapping transcripts">
##INFO=<ID=Aliases,Number=.,Type=String,Description="Previous names for the set of genes">
##INFO=<ID=Genes,Number=1,Type=Integer,Description="The number of genes overlapping this region.">
##INFO=<ID=TranscriptNameClinicallyRelevant,Number=.,Type=String,Description="The transcript determined to be clinically relevant among those found for the variant's interaction with the gene. If the variant affects multiple genes, one transcript from each gene is selected to be clinically relevant. The clinically relevant transcript is the transcript with the longest coding sequence among the transcripts with an LRG annotation. If a gene has no transcripts that are annotated with an LRG ID, the transcript with the longest coding sequence is used. For more information on how transcripts are chosen see our <a href='http://blog.goldenhelix.com/ajesaitis/whats-in-a-name-the-intricacies-of-identifying-variants/'>blog post on the topic</a>.">
##INFO=<ID=OverlappingExonsClinicallyRelevant,Number=.,Type=String,Description="Which exons of the transcript overlapping this region, or 'All' if they all overlap. Exon numbers are always numbered from the 5' UTR to the 3' UTR.">
##INFO=<ID=HGVSg,Number=1,Type=String,Description="The associated HGVS notation using the genomic reference sequence.">
##INFO=<ID=HGVScClinicallyRelevant,Number=.,Type=String,Description="The associated HGVS coding DNA notation with the clinically relevant transcript(s).">
##INFO=<ID=HGVSpClinicallyRelevant,Number=.,Type=String,Description="The associated HGVS protein change notation with the clinically relevant transcript(s).">
##INFO=<ID=ISCNCytobandNotation,Number=1,Type=String,Description="ISCN notation describing the overlapping cytobands.">
##INFO=<ID=SequenceOntologyClinicallyRelevant,Number=1,Type=String,Description="The sequence ontology associated with the clinically relevant transcript(s).">
##INFO=<ID=RegionClinicallyRelevant,Number=1,Type=String,Description="The region in which the variant is located. When a variant overlaps multiple regions, the region with the highest precedence is given. The order of precedence is defined as (from highest to lowest): exon, utr5, utr3, intron, intergenic.">
##INFO=<ID=Region,Number=.,Type=String,Description="The genomic position of the region.">
##INFO=<ID=Span2,Number=.,Type=Integer,Description="The size of the region (Stop-Stop).">
##INFO=<ID=OverlapType,Number=1,Type=String,Description="Specifies the way in which the CNV overlaps the region. Either \"Contains Region\", \"Within Region\", \"Identical\", or \"Partial Overlap\".">
##INFO=<ID=Name,Number=.,Type=String,Description="DGV Gene Name">
##INFO=<ID=Frequency,Number=.,Type=Float,Description="Samples Count / Num. of Unique Samples">
##INFO=<ID=Type2,Number=1,Type=String,Description="Gain or Loss">
##INFO=<ID=Region2,Number=.,Type=String,Description="The genomic position of the region.">
##INFO=<ID=Span3,Number=.,Type=Integer,Description="The size of the region (Stop-Stop).">
##INFO=<ID=OverlapType2,Number=1,Type=String,Description="Specifies the way in which the CNV overlaps the region. Either \"Contains Region\", \"Within Region\", \"Identical\", or \"Partial Overlap\".">
##INFO=<ID=Type3,Number=1,Type=String,Description="">
##INFO=<ID=Frequency2,Number=.,Type=Float,Description="">
##INFO=<ID=DeletionFrequency,Number=.,Type=Float,Description="">
##INFO=<ID=DuplicationFrequency,Number=.,Type=Float,Description="">
##FORMAT=<ID=CNVState,Number=1,Type=String,Description="State of the CNV event for each sample">
##FORMAT=<ID=AvgTargetMeanDepth,Number=1,Type=Float,Description="Average mean depth of the targets in this event as reported by Coverage Statistics">
##FORMAT=<ID=AvgZScore,Number=1,Type=Float,Description="Average Z-score of the targets in this event">
##FORMAT=<ID=AvgRatio,Number=1,Type=Float,Description="Average ratio of the targets in this event">
##FORMAT=<ID=pvalue,Number=1,Type=Float,Description="Probability that z-scores at least as extreme as those in the event would occur by chance in a normal region.">
##FORMAT=<ID=GeneList,Number=.,Type=String,Description="The genes that the cnv overlaps">
##FORMAT=<ID=CriticalGeneList,Number=.,Type=String,Description="The critical genes that the cnvs overlaps, these genes have established evidence for HI/TS. HI/TS maybe come from genes and regions in clingen or from the internal catalog of gene evaluations.">
##FORMAT=<ID=ScoredGene,Number=.,Type=String,Description="The gene with the maximum score for the gene specific criteria from the critical gene list. This gene has the strongest known effect.">
##FORMAT=<ID=ScoredGeneTranscript,Number=.,Type=String,Description="The transcript for the gene that was scored">
##FORMAT=<ID=Classification,Number=1,Type=String,Description="Classification of the score, this catagorizes the score to it pathogenicity based on the thresholds of Benign: score <= -1, Likely Benign: -1 < score <= -0.9, VUS: -0.9 < score < 0.9, Likely Pathogenic: 0.9 <= score < 1, Pathogenic: score <= 1.">
##FORMAT=<ID=Criteria,Number=.,Type=String,Description="The list of all of the criteria that were applied to reach the 'Total Score' and as a result the 'Classification'.">
##INFO=<ID=END,Number=1,Type=Integer,Description="">
##FORMAT=<ID=GT,Number=1,Type=String,Description="">
##FORMAT=<ID=CN,Number=1,Type=Integer,Description="">
#CHROM	POS	ID	REF	ALT	QUAL	FILTER	INFO	FORMAT	H110-301222-ROCHE_S58_R
1	16921989	.	N	<DUP>	.	.	Type=Gain;Targets=18;Samples2=5;Span=26934;GeneNames=CROCC;GeneIDs=9696;Aliases=ROLT,TAX1BP2;Genes=1;TranscriptNameClinicallyRelevant=NM_014675.5;OverlappingExonsClinicallyRelevant=1-19;HGVSg=NC_000001.11:g.16921989_16948922dup;HGVScClinicallyRelevant=NM_014675.5:c.1_2832dup;HGVSpClinicallyRelevant=NP_055490.4:p.M1_L944dup;ISCNCytobandNotation=dup(1)p36.13;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;Region=1:16850538-16959812,1:16886207-16946140,1:16898463-16972979,1:16904689-16940201,1:16918634-16935740;Span2=109275,59934,74517,35513,17107;OverlapType=Within Region,Partial Overlap,Within Region,Partial Overlap,Partial Overlap;Name=gssvG490,gssvG499,gssvG496,gssvG508,gssvG514;Frequency=0.1085,0.0018,0.0004,0.1346,0.0003;Type2=Gain,Gain,Gain,Gain,Gain;Region2=1:16861267-16969714,1:16918719-16935752,1:16925203-16938336;Span3=108448,17034,13134;OverlapType2=Within Region,Partial Overlap,Contains Region;Type3=Duplication,Duplication,Duplication;Frequency2=0.558371,0.00118263,0.00473373;DeletionFrequency=0,0,0;DuplicationFrequency=0.558371,0.00118263,0.00473373;END=16948922	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:123.284:1.71324:1.37015:4.14677346867954e-12:CROCC::CROCC:NM_014675.5:Benign:2L0ThiscnvpartiallyoverlapstheCROCCgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
1	103571593	.	N	<DUP>	.	.	Type=Gain;Targets=19;Samples2=3;Span=183230;GeneNames=AMY1A,AMY1B,AMY1C,AMY2A,AMY2B;GeneIDs=280,279,276,277,278;Aliases=AMY2,AMY3,HXA;Genes=5;TranscriptNameClinicallyRelevant=NM_004038.4,NM_001008218.2,NM_001008219.3,NM_000699.4,NM_001387437.1;OverlappingExonsClinicallyRelevant=All,All,1-8,All,All;HGVSg=NC_000001.11:g.103571593_103754822dup;HGVScClinicallyRelevant=.,.,NM_001008219.3:c.1_1101+8dup,.,.;HGVSpClinicallyRelevant=.,.,.,.,.;ISCNCytobandNotation=dup(1)p21.1;SequenceOntologyClinicallyRelevant=.,.,transcript_ablation,.,.;RegionClinicallyRelevant=.,.,exon,.,.;Region=1:103458409-103766545,1:103477937-103635416,1:103556018-103635416,1:103563013-103697364,1:103570917-103778627,1:103612150-103676538,1:103618378-103718572,1:103635404-103766545,1:103655567-103725600,1:103681656-103727325,1:103681656-103783855;Span2=308137,157480,79399,134352,207711,64389,100195,131142,70034,45670,102200;OverlapType=Within Region,Partial Overlap,Partial Overlap,Partial Overlap,Within Region,Contains Region,Contains Region,Partial Overlap,Contains Region,Contains Region,Partial Overlap;Name=gssvG1320,gssvG1324,gssvG1335,gssvG1328,gssvG1322,gssvG1337,gssvG1334,gssvG1330,gssvG1339,gssvG1341,gssvG1333;Frequency=0.016,0.0022,0.0432,0.0043,0.021,0.0095,0.0021,0.0106,0.0125,0.0019,0.0003;Type2=Gain,Gain,Gain,Gain,Gain,Gain,Gain,Gain,Gain,Gain,Gain;Region2=1:103561257-103616324,1:103566617-103635416,1:103566617-103725600,1:103620878-103725600,1:103678804-103760541;Span3=55068,68800,158984,104723,81738;OverlapType2=Partial Overlap,Partial Overlap,Partial Overlap,Contains Region,Partial Overlap;Type3=Duplication,Duplication,Duplication,Duplication,Duplication;Frequency2=0.125,0.0642,0.0214563,0.0114884,0.025;DeletionFrequency=0,0,0,0,0;DuplicationFrequency=0.125,0.0642,0.0214563,0.0114884,0.025;END=103754822	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:296.325:2.80382:1.51279:1.06861222086552e-31:AMY1A,AMY1B,AMY1C,AMY2A,AMY2B::AMY1A:NM_004038.4:Benign:2G0TheCNVisoverlapsthetriplobenignregionISCA-46321inClinGenDosageSensitivitybutincludesadditionalmaterial.,3A0Thiscnvoverlaps5proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
1	109687874	.	N	<DUP>	.	.	Type=Gain;Targets=8;Samples2=6;Span=24559;GeneNames=GSTM1,GSTM5;GeneIDs=2944,2949;Aliases=GST1,GSTM1-1,GSTM1a-1a,GSTM1b-1b,GTH4,GTM1,H-B,MU,MU-1;Genes=2;TranscriptNameClinicallyRelevant=NM_000561.4,NM_000851.4;OverlappingExonsClinicallyRelevant=All,1;HGVSg=NC_000001.11:g.109687874_109712432dup;HGVScClinicallyRelevant=.,NM_000851.4:c.1_36+84dup;HGVSpClinicallyRelevant=.,.;ISCNCytobandNotation=dup(1)p13.3;SequenceOntologyClinicallyRelevant=.,transcript_ablation;RegionClinicallyRelevant=.,exon;Region=1:109613590-109721978,1:109657077-109712158,1:109668513-109741677,1:109676374-109701420,1:109679093-109713598,1:109687453-109703496,1:109699584-109715089;Span2=108389,55082,73165,25047,34506,16044,15506;OverlapType=Within Region,Partial Overlap,Within Region,Partial Overlap,Within Region,Partial Overlap,Partial Overlap;Name=gssvG1466,gssvG1468,gssvG1467,gssvG1470,gssvG1469,gssvG1474,gssvG1472;Frequency=0.0041,0.0034,0.0016,0.1177,0.0172,0.0091,0.0111;Type2=Gain,Gain,Gain,Gain,Gain,Gain,Gain;Region2=1:109648283-109714708,1:109672391-109702309,1:109687814-109697626,1:109689257-109697626,1:109702377-109710508;Span3=66426,29919,9813,8370,8132;OverlapType2=Within Region,Partial Overlap,Partial Overlap,Contains Region,Contains Region;Type3=Duplication,Duplication,Duplication,Duplication,Duplication;Frequency2=0.65,0.584444,0.00118343,0.0106509,0.000168947;DeletionFrequency=0,0,0,0,0;DuplicationFrequency=0.65,0.584444,0.00118343,0.0106509,0.000168947;END=109712432	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:161.913:1.62115:1.78158:1.30980490376184e-05:GSTM1,GSTM5::GSTM5:NM_000851.4:Benign:2L0ThiscnvpartiallyoverlapstheGSTM5genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
1	151847289	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=1;Span=120;GeneNames=C2CD4D-AS1,THEM5;GeneIDs=100132111,284486;Genes=2;TranscriptNameClinicallyRelevant=NR_024237.2,NM_182578.4;OverlappingExonsClinicallyRelevant=.,6;HGVSg=NC_000001.11:g.151847289_151847408dup;HGVScClinicallyRelevant=.,NM_182578.4:c.744_*1ins(38);HGVSpClinicallyRelevant=.,NP_872384.2:p.F236;ISCNCytobandNotation=dup(1)q21.3;SequenceOntologyClinicallyRelevant=.,stop_retained_variant;RegionClinicallyRelevant=.,exon;END=151847408	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:117.083:4.79082:1.77749:4.44340559243324e-06:C2CD4D-AS1,THEM5::THEM5:NM_182578.4:VUS:2L0ThiscnvpartiallyoverlapstheTHEM5genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
2	227598878	.	N	<DUP>	.	.	Type=Gain;Targets=8;Samples2=1;Span=18974;GeneNames=C2orf83,LOC729968,SCYGR2,SCYGR3,SCYGR4,SCYGR10;GeneIDs=112441435,112441436,56918,112441429,729968,112441430;Aliases=KRTAP28-2;Genes=6;TranscriptNameClinicallyRelevant=NR_172912.1,NR_149019.1,NM_001395403.1,NM_001395404.1,NM_001395405.1,NR_173327.1;OverlappingExonsClinicallyRelevant=3-4,All,All,All,All,All;HGVSg=NC_000002.12:g.227598878_227617851dup;HGVScClinicallyRelevant=.,.,.,.,.,.;HGVSpClinicallyRelevant=.,.,.,.,.,.;ISCNCytobandNotation=dup(2)q36.3;SequenceOntologyClinicallyRelevant=.,.,.,.,.,.;RegionClinicallyRelevant=.,.,.,.,.,.;END=227617851	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:198.989:3.02674:1.31342:2.30791908928066e-16:C2orf83,LOC729968,SCYGR2,SCYGR3,SCYGR4,SCYGR10::.:.:VUS:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps3proteincodinggenes:3
3	13480684	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=1;Span=120;GeneNames=HDAC11;GeneIDs=79885;Aliases=HD11;Genes=1;TranscriptNameClinicallyRelevant=NM_024827.4;OverlappingExonsClinicallyRelevant=.;HGVSg=NC_000003.12:g.13480684_13480803dup;HGVScClinicallyRelevant=NM_024827.4:c.2+334_2+335ins(120);HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(3)p25.1;SequenceOntologyClinicallyRelevant=intron_variant;RegionClinicallyRelevant=intron;END=13480803	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:132.117:5.35363:1.6495:2.82226820352769e-07:HDAC11::HDAC11:NM_024827.4:VUS:2L0ThiscnvpartiallyoverlapstheHDAC11genewhichhasunknownclinicalsignificance,1B-0.6TheCNVdoesnotoverlapthecodingregionofanygenes:3
3	195870099	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=1;Span=120;GeneNames=TNK2;GeneIDs=10188;Aliases=ACK,ACK-1,ACK1,p21cdc42Hs;Genes=1;TranscriptNameClinicallyRelevant=NM_005781.5;OverlappingExonsClinicallyRelevant=11;HGVSg=NC_000003.12:g.195870099_195870218dup;HGVScClinicallyRelevant=NM_005781.5:c.1452-13_1543+15dup;HGVSpClinicallyRelevant=NP_005772.3:p.K515Nfs*14;ISCNCytobandNotation=dup(3)q29;SequenceOntologyClinicallyRelevant=frameshift_variant;RegionClinicallyRelevant=exon;END=195870218	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:129.225:8.26921:1.858:1.78298750096472e-15:TNK2::TNK2:NM_005781.5:VUS:2L0ThiscnvpartiallyoverlapstheTNK2genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
4	98928874	.	N	<DUP>	.	.	Type=Gain;Targets=3;Samples2=1;Span=66996;GeneNames=EIF4E,METAP1;GeneIDs=1977,23173;Aliases=AUTS19,CBP,EIF4E1,EIF4EL1,EIF4F,eIF-4E;Genes=2;TranscriptNameClinicallyRelevant=NM_001968.5,NM_015143.3;OverlappingExonsClinicallyRelevant=1,1;HGVSg=NC_000004.12:g.98928874_98995869dup;HGVScClinicallyRelevant=NM_001968.5:c.1_18+221dup,NM_015143.3:c.1_114+2dup;HGVSpClinicallyRelevant=.,.;ISCNCytobandNotation=dup(4)q23;SequenceOntologyClinicallyRelevant=transcript_ablation,transcript_ablation;RegionClinicallyRelevant=exon,exon;END=98995869	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:103.747:2.91339:1.36288:1.40516308778484e-06:EIF4E,METAP1::EIF4E:NM_001968.5:VUS:2L0ThiscnvpartiallyoverlapstheEIF4Egenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
5	1038342	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=1;Span=120;GeneNames=NKD2;GeneIDs=85409;Aliases=Naked2;Genes=1;TranscriptNameClinicallyRelevant=NM_033120.4;OverlappingExonsClinicallyRelevant=10;HGVSg=NC_000005.10:g.1038342_1038461dup;HGVScClinicallyRelevant=NM_033120.4:c.1324_1325ins(32);HGVSpClinicallyRelevant=NP_149111.1:p.H442;ISCNCytobandNotation=dup(5)p15.33;SequenceOntologyClinicallyRelevant=stop_retained_variant;RegionClinicallyRelevant=exon;END=1038461	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:152.792:5.63269:1.67475:6.47258095523507e-08:NKD2::NKD2:NM_033120.4:Benign:2L0ThiscnvpartiallyoverlapstheNKD2genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
6	35787000	.	N	<DUP>	.	.	Type=Gain;Targets=6;Samples2=10;Span=10307;GeneNames=CLPS,CLPSL1;GeneIDs=340204,1208;Aliases=C6orf127,ESP32,dJ510O8.6;Genes=2;TranscriptNameClinicallyRelevant=NM_001832.4,NM_001010886.5;OverlappingExonsClinicallyRelevant=All,2-3;HGVSg=NC_000006.12:g.35787000_35797306dup;HGVScClinicallyRelevant=.,NM_001010886.5:c.102_366dup;HGVSpClinicallyRelevant=.,.;ISCNCytobandNotation=dup(6)p21.31;SequenceOntologyClinicallyRelevant=.,3_prime_UTR_variant;RegionClinicallyRelevant=.,UTR3;Region=6:35776413-35799223,6:35786739-35798799,6:35786775-35815720;Span2=22811,12061,28946;OverlapType=Within Region,Within Region,Within Region;Name=gssvG32237,gssvG32240,gssvG32236;Frequency=0.6878,0.0083,0.0033;Type2=Gain,Gain,Gain;Region2=6:35785282-35798892,6:35792975-35797350;Span3=13611,4376;OverlapType2=Within Region,Partial Overlap;Type3=Duplication,Duplication;Frequency2=0.825,0.0106509;DeletionFrequency=0,0;DuplicationFrequency=0.825,0.0106509;END=35797306	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:162.59:2.29677:1.42455:7.71912269050046e-08:CLPS,CLPSL1::CLPSL1:NM_001010886.5:Benign:2L0ThiscnvpartiallyoverlapstheCLPSL1genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
7	76303770	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=1;Span=120;GeneNames=HSPB1;GeneIDs=3315;Aliases=CMT2F,HEL-S-102,HMN2B,HS.76067,HSP27,HSP28,Hsp25,SRP27;Genes=1;TranscriptNameClinicallyRelevant=NM_001540.5;OverlappingExonsClinicallyRelevant=2;HGVSg=NC_000007.14:g.76303770_76303889dup;HGVScClinicallyRelevant=NM_001540.5:c.365-32_428+24dup;HGVSpClinicallyRelevant=NP_001531.1:p.L144Qfs*38;ISCNCytobandNotation=dup(7)q11.23;SequenceOntologyClinicallyRelevant=frameshift_variant;RegionClinicallyRelevant=exon;END=76303889	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:94.15:5.31729:1.87883:3.40128535257128e-07:HSPB1::HSPB1:NM_001540.5:VUS:2L0ThiscnvpartiallyoverlapstheHSPB1genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
7	78026027	.	N	<DEL>	.	.	Type=Loss;Targets=1;Samples2=1;Span=120;GeneNames=MAGI2;GeneIDs=9863;Aliases=ACVRIP1,AIP-1,AIP1,ARIP1,MAGI-2,NPHS15,SSCAM;Genes=1;TranscriptNameClinicallyRelevant=NM_012301.4;OverlappingExonsClinicallyRelevant=.;HGVSg=NC_000007.14:g.78026027_78026146del;HGVScClinicallyRelevant=NM_012301.4:c.3707-6170_3707-6051del;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=del(7)q21.11;SequenceOntologyClinicallyRelevant=intron_variant;RegionClinicallyRelevant=intron;END=78026146	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:42.2667:-4.79441:0.407612:3.69899264709944e-06:MAGI2::MAGI2:NM_012301.4:VUS:2H0.15TheMAGI2genehasagnomadobserved/expectedfrequencyof0.257andadecipherhiindexof2.52.,1B-0.6TheCNVdoesnotoverlapthecodingregionofanygenes:1
7	142065578	.	N	<DEL>	.	.	Type=Loss;Targets=15;Samples2=2;Span=19064;GeneNames=MGAM;GeneIDs=8972;Aliases=MG;Genes=1;TranscriptNameClinicallyRelevant=NM_004668.3;OverlappingExonsClinicallyRelevant=.;HGVSg=NC_000007.14:g.142065578_142084641del;HGVScClinicallyRelevant=NM_004668.3:c.4618+110_4619-9979del;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=del(7)q34;SequenceOntologyClinicallyRelevant=intron_variant;RegionClinicallyRelevant=intron;Region=7:142041807-142099348,7:142050223-142084684,7:142060398-142099360,7:142065905-142086994;Span2=57542,34462,38963,21090;OverlapType=Within Region,Within Region,Within Region,Partial Overlap;Name=gssvL119327,gssvL119329,gssvL119328,gssvL119332;Frequency=0.0441,0.0027,0.0409,0.0073;Type2=Loss,Loss,Loss,Loss;Region2=7:142060932-142093800,7:142065727-142078454,7:142078905-142086749;Span3=32869,12728,7845;OverlapType2=Within Region,Contains Region,Partial Overlap;Type3=Deletion,Deletion,Deletion;Frequency2=0.279598,0.00118343,0.00118343;DeletionFrequency=0.279598,0.00118343,0.00118343;DuplicationFrequency=0,0,0;END=142084641	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:63.7884:-1.51619:0.582656:1.05668664735213e-08:MGAM::MGAM:NM_004668.3:Benign:2F-1ThecnvdoesnotincludeanyproteincodinggenesoutsideoftheknownhaplobenignregionISCA-46375inClinGenDosageSensitivity.,1B-0.6TheCNVdoesnotoverlapthecodingregionofanygenes:1
7	144398261	.	N	<DUP>	.	.	Type=Gain;Targets=3;Samples2=1;Span=926;GeneNames=NOBOX;GeneIDs=135935;Aliases=OG-2,OG2,OG2X,POF5,TCAG_12042;Genes=1;TranscriptNameClinicallyRelevant=NM_001080413.3;OverlappingExonsClinicallyRelevant=8-9;HGVSg=NC_000007.14:g.144398261_144399186dup;HGVScClinicallyRelevant=NM_001080413.3:c.1241-8_1774+21dup;HGVSpClinicallyRelevant=NP_001073882.3:p.E414_I591dup;ISCNCytobandNotation=dup(7)q35;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=144399186	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:130.109:4.18598:1.47684:3.45613039173643e-12:NOBOX::NOBOX:NM_001080413.3:Benign:2L0ThiscnvpartiallyoverlapstheNOBOXgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
8	22196670	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=1;Span=180;GeneNames=BMP1;GeneIDs=649;Aliases=OI13,PCOLC,PCP,TLD;Genes=1;TranscriptNameClinicallyRelevant=NM_006129.5;OverlappingExonsClinicallyRelevant=14;HGVSg=NC_000008.11:g.22196670_22196849dup;HGVScClinicallyRelevant=NM_006129.5:c.1766-10_1926+9dup;HGVSpClinicallyRelevant=NP_006120.1:p.V643Lfs*163;ISCNCytobandNotation=dup(8)p21.3;SequenceOntologyClinicallyRelevant=frameshift_variant;RegionClinicallyRelevant=exon;END=22196849	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:174.544:5.92177:1.63151:1.30723670562609e-08:BMP1::BMP1:NM_006129.5:VUS:2L0ThiscnvpartiallyoverlapstheBMP1genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
9	137021886	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=1;Span=120;GeneNames=ABCA2;GeneIDs=20;Aliases=ABC2,IDPOGSA;Genes=1;TranscriptNameClinicallyRelevant=NM_212533.3;OverlappingExonsClinicallyRelevant=7;HGVSg=NC_000009.12:g.137021886_137022005dup;HGVScClinicallyRelevant=NM_212533.3:c.658-4_768+5dup;HGVSpClinicallyRelevant=NP_997698.1:p.V220_E256dup;ISCNCytobandNotation=dup(9)q34.3;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=137022005	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:244.392:6.18588:1.59653:2.83715770151182e-09:ABCA2::ABCA2:NM_212533.3:VUS:2L0ThiscnvpartiallyoverlapstheABCA2genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
11	1092361	.	N	<DUP>	.	.	Type=Gain;Targets=5;Samples2=1;Span=3382;GeneNames=MUC2;GeneIDs=4583;Aliases=MLP,MUC-2,SMUC;Genes=1;TranscriptNameClinicallyRelevant=NM_002457.4;OverlappingExonsClinicallyRelevant=27-30;HGVSg=NC_000011.10:g.1092361_1095742dup;HGVScClinicallyRelevant=NM_002457.4:c.3633-38_5499dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(11)p15.5;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=1095742	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:144.87:3.83078:1.3506:2.02302557705262e-16:MUC2::MUC2:NM_002457.4:Benign:2L0ThiscnvpartiallyoverlapstheMUC2genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
11	1565713	.	N	<DUP>	.	.	Type=Gain;Targets=11;Samples2=1;Span=131982;GeneNames=DUSP8,FAM99A,FAM99B,KRTAP5-1,KRTAP5-2,KRTAP5-3,KRTAP5-4,KRTAP5-5,KRTAP5-6,KRTAP5-AS1;GeneIDs=1850,338651,387264,440021,387266,387267,439915,387742,100132464,440023;Aliases=C11orf81,HB5,HVH-5,HVH8;Genes=10;TranscriptNameClinicallyRelevant=NM_004420.3,NR_026643.1,NR_026642.1,NM_001005922.1,NM_001004325.2,NM_001012708.2,NM_001347674.1,NM_001001480.3,NM_001012416.1,NR_021489.2;OverlappingExonsClinicallyRelevant=1-2,All,All,All,All,All,All,All,All,All;HGVSg=NC_000011.10:g.1565713_1697694dup;HGVScClinicallyRelevant=NM_004420.3:c.1_114dup,.,.,.,.,.,.,.,.,.;HGVSpClinicallyRelevant=NP_004411.2:p.M1_Y38dup,.,.,.,.,.,.,.,.,.;ISCNCytobandNotation=dup(11)p15.5;SequenceOntologyClinicallyRelevant=inframe_insertion,.,.,.,.,.,.,.,.,.;RegionClinicallyRelevant=exon,.,.,.,.,.,.,.,.,.;Region=11:1575016-1713002;Span2=137987;OverlapType=Partial Overlap;Name=gssvG5879;Frequency=0.0002;Type2=Gain;END=1697694	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:236.198:4.83667:1.35344:1.20255909925127e-53:DUSP8,FAM99A,FAM99B,KRTAP5-1,KRTAP5-2,KRTAP5-3,KRTAP5-4,KRTAP5-5,KRTAP5-6,KRTAP5-AS1::DUSP8:NM_004420.3:VUS:2L0ThiscnvpartiallyoverlapstheDUSP8genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps7proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
11	2422131	.	N	<DUP>	.	.	Type=Gain;Targets=5;Samples2=1;Span=39642;GeneNames=KCNQ1,TRPM5;GeneIDs=29850,3784;Aliases=LTRPC5,MTR1;Genes=2;TranscriptNameClinicallyRelevant=NM_000218.3,NM_014555.4;OverlappingExonsClinicallyRelevant=1,1-7;HGVSg=NC_000011.10:g.2422131_2461772dup;HGVScClinicallyRelevant=NM_000218.3:c.1_386+16288dup,NM_014555.4:c.1_298+10dup;HGVSpClinicallyRelevant=.,.;ISCNCytobandNotation=dup(11)p15.5;SequenceOntologyClinicallyRelevant=transcript_ablation,transcript_ablation;RegionClinicallyRelevant=exon,exon;END=2461772	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:115.201:2.4846:1.29135:1.10062769565022e-07:KCNQ1,TRPM5:KCNQ1:KCNQ1:NM_000218.3:VUS:2J0ThiscnvpartiallyoverlapstheKCNQ1gene,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
11	17643424	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=1;Span=120;GeneNames=OTOG;GeneIDs=340990;Aliases=DFNB18B,MLEMP,OTGN;Genes=1;TranscriptNameClinicallyRelevant=NM_001277269.2;OverlappingExonsClinicallyRelevant=53;HGVSg=NC_000011.10:g.17643424_17643543dup;HGVScClinicallyRelevant=NM_001277269.2:c.8452-37_8497+37dup;HGVSpClinicallyRelevant=NP_001264198.1:p.K2834Wfs*16;ISCNCytobandNotation=dup(11)p15.1;SequenceOntologyClinicallyRelevant=frameshift_variant;RegionClinicallyRelevant=exon;END=17643543	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:208.683:6.45627:1.54505:5.5607773497062e-10:OTOG::OTOG:NM_001277269.2:VUS:2L0ThiscnvpartiallyoverlapstheOTOGgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
11	71501267	.	N	<DUP>	.	.	Type=Gain;Targets=11;Samples2=1;Span=286374;GeneNames=KRTAP5-7,KRTAP5-8,KRTAP5-9,KRTAP5-10,KRTAP5-11,NADSYN1;GeneIDs=55191,440050,57830,3846,387273,440051;Aliases=VCRL3;Genes=6;TranscriptNameClinicallyRelevant=NM_001012503.2,NM_021046.3,NM_005553.4,NM_001012710.2,NM_001005405.3,NM_018161.5;OverlappingExonsClinicallyRelevant=All,All,All,All,All,21;HGVSg=NC_000011.10:g.71501267_71787640dup;HGVScClinicallyRelevant=.,.,.,.,.,NM_018161.5:c.2071-35_2121dup;HGVSpClinicallyRelevant=.,.,.,.,.,.;ISCNCytobandNotation=dup(11)q13.4;SequenceOntologyClinicallyRelevant=.,.,.,.,.,transcript_ablation;RegionClinicallyRelevant=.,.,.,.,.,exon;Region=11:71582829-71731620,11:71582829-71908877;Span2=148792,326049;OverlapType=Contains Region,Partial Overlap;Name=gssvG6929,gssvG6927;Frequency=0.0002,0.0019;Type2=Gain,Gain;Region2=11:71649145-71825826;Span3=176682;OverlapType2=Partial Overlap;Type3=Duplication;Frequency2=0.000168947;DeletionFrequency=0;DuplicationFrequency=0.000168947;END=71787640	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:241.983:2.60293:1.1855:1.3849350971827e-16:KRTAP5-7,KRTAP5-8,KRTAP5-9,KRTAP5-10,KRTAP5-11,NADSYN1::NADSYN1:NM_018161.5:VUS:2L0ThiscnvpartiallyoverlapstheNADSYN1genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps6proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
11	115209603	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=1;Span=120;GeneNames=CADM1;GeneIDs=23705;Aliases=BL2,IGSF4,IGSF4A,NECL2,Necl-2,RA175,ST17,SYNCAM,TSLC1,sTSLC-1,sgIGSF,synCAM1;Genes=1;TranscriptNameClinicallyRelevant=NM_014333.4;OverlappingExonsClinicallyRelevant=8;HGVSg=NC_000011.10:g.115209603_115209722dup;HGVScClinicallyRelevant=NM_014333.4:c.1049_1050ins(120);HGVSpClinicallyRelevant=NP_055148.3:p.?;ISCNCytobandNotation=dup(11)q23.3;SequenceOntologyClinicallyRelevant=splice_acceptor_variant;RegionClinicallyRelevant=exon;END=115209722	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:153.4:6.03548:1.95882:6.82453895326724e-09:CADM1::CADM1:NM_014333.4:VUS:2L0ThiscnvpartiallyoverlapstheCADM1genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
12	11267104	.	N	<DUP>	.	.	Type=Gain;Targets=3;Samples2=1;Span=1134;GeneNames=PRB3;GeneIDs=5544;Aliases=G1,PRG;Genes=1;TranscriptNameClinicallyRelevant=NM_001394862.1;OverlappingExonsClinicallyRelevant=3;HGVSg=NC_000012.12:g.11267104_11268237dup;HGVScClinicallyRelevant=NM_001394862.1:c.101-89_1056dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(12)p13.2;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=11268237	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:144.443:3.80613:1.41713:2.59139219392301e-10:PRB3::PRB3:NM_001394862.1:VUS:2L0ThiscnvpartiallyoverlapsthePRB3genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
14	105766307	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=1;Span=1302;END=105767608	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:102.682:5.00029:1.53714:1.11838074131315e-11:::.:.:Benign:1B-0.6TheCNVdoesnotoverlapanygenes,2D-1ThecnvissmallerthanthetriplobenignregionISCA-37477inClinGenDosageSensitivityanddoesnotinteruptanyprotiencodinggenes,3A0Thiscnvoverlaps0proteincodinggenes:3
14	106268617	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=2;Span=544;Region2=14:106268775-106269095;Span3=321;OverlapType2=Contains Region;Type3=Duplication;Frequency2=0.00118343;DeletionFrequency=0;DuplicationFrequency=0.00118343;END=106269160	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:572.542:3.3094:1.68046:7.64047104489188e-06:::.:.:Benign:1B-0.6TheCNVdoesnotoverlapanygenes,2D-1ThecnvissmallerthanthetriplobenignregionISCA-37477inClinGenDosageSensitivityanddoesnotinteruptanyprotiencodinggenes,3A0Thiscnvoverlaps0proteincodinggenes:3
16	29461298	.	N	<DUP>	.	.	Type=Gain;Targets=3;Samples2=4;Span=38123;GeneNames=LOC388242,NPIPB12,SLX1B-SULT1A4,SULT1A4;GeneIDs=100526831,445329,388242,440353;Genes=4;TranscriptNameClinicallyRelevant=NR_002556.1,NM_001355401.2,NR_037609.1,NM_001017390.3;OverlappingExonsClinicallyRelevant=All,3-8,5-11,2-8;HGVSg=NC_000016.10:g.29461298_29499420dup;HGVScClinicallyRelevant=.,NM_001355401.2:c.121-3813_2787dup,.,.;HGVSpClinicallyRelevant=.,.,.,.;ISCNCytobandNotation=dup(16)p11.2;SequenceOntologyClinicallyRelevant=.,transcript_ablation,.,.;RegionClinicallyRelevant=.,exon,.,.;Region=16:29447609-29477726;Span2=30118;OverlapType=Partial Overlap;Name=gssvG14565;Frequency=0.0882;Type2=Gain;Region2=16:29447610-29476289,16:29449353-29554098,16:29449601-29476289;Span3=28680,104746,26689;OverlapType2=Partial Overlap,Within Region,Partial Overlap;Type3=Duplication,Duplication,Duplication;Frequency2=0.025,0.05,0.025;DeletionFrequency=0,0,0;DuplicationFrequency=0.025,0.05,0.025;END=29499420	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:34.6226:2.3036:2.48974:0.000145052689232067:LOC388242,NPIPB12,SLX1B-SULT1A4,SULT1A4::NPIPB12:NM_001355401.2:Benign:2L0ThiscnvpartiallyoverlapstheNPIPB12genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
16	66940213	.	N	<DUP>	.	.	Type=Gain;Targets=34;Samples2=1;Span=89294;GeneNames=CBFB,CES2,CES3,CES4A;GeneIDs=8824,23491,283848,865;Aliases=CE-2,CES2A1,PCE-2,iCE;Genes=4;TranscriptNameClinicallyRelevant=NM_022845.3,NM_001365405.1,NM_024922.6,NM_001364782.1;OverlappingExonsClinicallyRelevant=1,4-12,All,All;HGVSg=NC_000016.10:g.66940213_67029506dup;HGVScClinicallyRelevant=NM_022845.3:c.1_78+21dup,NM_001365405.1:c.424-9_1680dup,.,.;HGVSpClinicallyRelevant=.,.,.,.;ISCNCytobandNotation=dup(16)q22.1;SequenceOntologyClinicallyRelevant=transcript_ablation,transcript_ablation,.,.;RegionClinicallyRelevant=exon,exon,.,.;END=67029506	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:231.759:5.97546:1.63173:8.23367115754848e-246:CBFB,CES2,CES3,CES4A::CBFB:NM_022845.3:VUS:2L0ThiscnvpartiallyoverlapstheCBFBgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps4proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
17	18127060	.	N	<DUP>	.	.	Type=Gain;Targets=3;Samples2=1;Span=3911;GeneNames=MYO15A;GeneIDs=51168;Aliases=DFNB3,MYO15;Genes=1;TranscriptNameClinicallyRelevant=NM_016239.4;OverlappingExonsClinicallyRelevant=7-8;HGVSg=NC_000017.11:g.18127060_18130970dup;HGVScClinicallyRelevant=NM_016239.4:c.3942-15_4038+160dup;HGVSpClinicallyRelevant=NP_057323.3:p.I1347Wfs*9;ISCNCytobandNotation=dup(17)p11.2;SequenceOntologyClinicallyRelevant=frameshift_variant;RegionClinicallyRelevant=exon;END=18130970	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:111.036:3.53459:1.54561:4.45717701760247e-09:MYO15A::MYO15A:NM_016239.4:VUS:2B0WhiletheCNVoverlapstheMYO15AgeneitisunclearifthisisthecausativegeneforhaploinsufficientregionISCA-37418inClinGenDosageSensitivity.,2L0ThiscnvpartiallyoverlapstheMYO15Agenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
17	39184764	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=1;Span=120;GeneNames=CACNB1;GeneIDs=782;Aliases=CAB1,CACNLB1,CCHLB1;Genes=1;TranscriptNameClinicallyRelevant=NM_000723.5;OverlappingExonsClinicallyRelevant=8;HGVSg=NC_000017.11:g.39184764_39184883dup;HGVScClinicallyRelevant=NM_000723.5:c.649-19_729+20dup;HGVSpClinicallyRelevant=NP_000714.3:p.T217_E243dup;ISCNCytobandNotation=dup(17)q12;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=39184883	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:122.125:5.92321:1.85274:1.29666442788834e-08:CACNB1::CACNB1:NM_000723.5:VUS:2L0ThiscnvpartiallyoverlapstheCACNB1genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
17	44117444	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=1;Span=120;GeneNames=HDAC5,LOC105371789;GeneIDs=10014,105371789;Aliases=HD5,NY-CO-9;Genes=2;TranscriptNameClinicallyRelevant=NM_001015053.2,NR_136415.1;OverlappingExonsClinicallyRelevant=2,.;HGVSg=NC_000017.11:g.44117444_44117563dup;HGVScClinicallyRelevant=NM_001015053.2:c.1_22+50dup,.;HGVSpClinicallyRelevant=.,.;ISCNCytobandNotation=dup(17)q21.31;SequenceOntologyClinicallyRelevant=transcript_ablation,.;RegionClinicallyRelevant=exon,.;END=44117563	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:151.583:5.22598:1.63231:5.40723460338769e-07:HDAC5,LOC105371789::HDAC5:NM_001015053.2:VUS:2L0ThiscnvpartiallyoverlapstheHDAC5genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
17	79796905	.	N	<DUP>	.	.	Type=Gain;Targets=3;Samples2=1;Span=38685;GeneNames=CBX4,CBX8,LINC01977;GeneIDs=57332,105371919,8535;Aliases=PC3,RC1;Genes=3;TranscriptNameClinicallyRelevant=NM_003655.3,NM_020649.3,NR_146504.1;OverlappingExonsClinicallyRelevant=5,1,All;HGVSg=NC_000017.11:g.79796905_79835589dup;HGVScClinicallyRelevant=NM_003655.3:c.246+57_1683dup,NM_020649.3:c.1_69+25dup,.;HGVSpClinicallyRelevant=.,.,.;ISCNCytobandNotation=dup(17)q25.3;SequenceOntologyClinicallyRelevant=transcript_ablation,transcript_ablation,.;RegionClinicallyRelevant=exon,exon,.;END=79835589	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:167.346:3.27215:1.3654:5.75365844220798e-08:CBX4,CBX8,LINC01977::CBX4:NM_003655.3:VUS:2L0ThiscnvpartiallyoverlapstheCBX4genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
19	13207254	.	N	<DUP>	.	.	Type=Gain;Targets=4;Samples2=1;Span=1771;GeneNames=CACNA1A;GeneIDs=773;Aliases=APCA,BI,CACNL1A4,CAV2.1,DEE42,EA2,EIEE42,FHM,MHP,MHP1,SCA6;Genes=1;TranscriptNameClinicallyRelevant=NM_001127221.2;OverlappingExonsClinicallyRelevant=46-47;HGVSg=NC_000019.10:g.13207254_13209024dup;HGVScClinicallyRelevant=NM_001127221.2:c.6530-15_6786dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(19)p13.13;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=13209024	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:103.211:2.84026:1.34886:5.50422114529016e-08:CACNA1A:CACNA1A:CACNA1A:NM_001127221.2:VUS:2J0ThiscnvpartiallyoverlapstheCACNA1Agene,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
19	15461050	.	N	<DUP>	.	.	Type=Gain;Targets=4;Samples2=1;Span=3323;GeneNames=RASAL3;GeneIDs=64926;Genes=1;TranscriptNameClinicallyRelevant=NM_022904.3;OverlappingExonsClinicallyRelevant=2-5;HGVSg=NC_000019.10:g.15461050_15464372dup;HGVScClinicallyRelevant=NM_022904.3:c.1_606+10dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(19)p13.12;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=15464372	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:153.562:3.20136:1.30056:8.60742232623585e-10:RASAL3::RASAL3:NM_022904.3:VUS:2L0ThiscnvpartiallyoverlapstheRASAL3genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
19	17332920	.	N	<DUP>	.	.	Type=Gain;Targets=10;Samples2=8;Span=6689;GeneNames=ANO8,GTPBP3;GeneIDs=57719,84705;Aliases=KIAA1623,TMEM16H;Genes=2;TranscriptNameClinicallyRelevant=NM_020959.3,NM_133644.4;OverlappingExonsClinicallyRelevant=1-5,1-6;HGVSg=NC_000019.10:g.17332920_17339608dup;HGVScClinicallyRelevant=NM_020959.3:c.1_586+10dup,NM_133644.4:c.1_1070+9dup;HGVSpClinicallyRelevant=.,.;ISCNCytobandNotation=dup(19)p13.11;SequenceOntologyClinicallyRelevant=transcript_ablation,transcript_ablation;RegionClinicallyRelevant=exon,exon;Region=19:17331902-17339470;Span2=7569;OverlapType=Partial Overlap;Name=gssvG18597;Frequency=0.0251;Type2=Gain;Region2=19:17331799-17339584,19:17332441-17339470,19:17332441-17339470,19:17335001-17337799,19:17337585-17339724;Span3=7786,7030,7030,2799,2140;OverlapType2=Partial Overlap,Partial Overlap,Partial Overlap,Contains Region,Partial Overlap;Type3=Duplication,Duplication,Duplication,Duplication,Duplication;Frequency2=0.0461538,0.025,0.0133333,0.00118343,0.00591716;DeletionFrequency=0,0,0,0,0;DuplicationFrequency=0.0461538,0.025,0.0133333,0.00118343,0.00591716;END=17339608	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:150.326:2.44102:1.33399:1.50839460487053e-13:ANO8,GTPBP3::ANO8:NM_020959.3:VUS:2L0ThiscnvpartiallyoverlapstheANO8genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
19	17623485	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=1;Span=120;GeneNames=UNC13A;GeneIDs=23025;Aliases=Munc13-1;Genes=1;TranscriptNameClinicallyRelevant=NM_001080421.3;OverlappingExonsClinicallyRelevant=36;HGVSg=NC_000019.10:g.17623485_17623604dup;HGVScClinicallyRelevant=NM_001080421.3:c.4198-57_4203+57dup;HGVSpClinicallyRelevant=NP_001073890.2:p.M1400_I1401dup;ISCNCytobandNotation=dup(19)p13.11;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=17623604	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:72.975:4.37444:1.65829:2.84485753000297e-05:UNC13A::UNC13A:NM_001080421.3:VUS:2L0ThiscnvpartiallyoverlapstheUNC13Agenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
19	18431326	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=1;Span=120;GeneNames=SSBP4;GeneIDs=170463;Genes=1;TranscriptNameClinicallyRelevant=NM_032627.5;OverlappingExonsClinicallyRelevant=6;HGVSg=NC_000019.10:g.18431326_18431445dup;HGVScClinicallyRelevant=NM_032627.5:c.370-27_435+27dup;HGVSpClinicallyRelevant=NP_116016.1:p.G124_Q145dup;ISCNCytobandNotation=dup(19)p13.11;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=18431445	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:108.175:5.5868:1.71434:8.28633112726442e-08:SSBP4::SSBP4:NM_032627.5:VUS:2L0ThiscnvpartiallyoverlapstheSSBP4genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
19	19145684	.	N	<DUP>	.	.	Type=Gain;Targets=4;Samples2=1;Span=1508;GeneNames=BORCS8-MEF2B,MEF2B;GeneIDs=100271849,4207;Aliases=RSRFR2;Genes=2;TranscriptNameClinicallyRelevant=NM_005919.4,NM_001145785.2;OverlappingExonsClinicallyRelevant=7-10,5-9;HGVSg=NC_000019.10:g.19145684_19147191dup;HGVScClinicallyRelevant=NM_005919.4:c.394-8_1098dup,NM_001145785.2:c.394-8_1107dup;HGVSpClinicallyRelevant=.,.;ISCNCytobandNotation=dup(19)p13.11;SequenceOntologyClinicallyRelevant=transcript_ablation,transcript_ablation;RegionClinicallyRelevant=exon,exon;END=19147191	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:97.1821:2.43596:1.28661:3.3071455071272e-06:BORCS8-MEF2B,MEF2B::BORCS8-MEF2B:NM_005919.4:VUS:2L0ThiscnvpartiallyoverlapstheBORCS8-MEF2Bgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
19	43607518	.	N	<DUP>	.	.	Type=Gain;Targets=3;Samples2=1;Span=688;GeneNames=ZNF428;GeneIDs=126299;Aliases=C19orf37,Zfp428;Genes=1;TranscriptNameClinicallyRelevant=NM_182498.4;OverlappingExonsClinicallyRelevant=3;HGVSg=NC_000019.10:g.43607518_43608205dup;HGVScClinicallyRelevant=NM_182498.4:c.77-98_567dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(19)q13.31;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=43608205	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:99.3833:3.89659:1.43504:9.6078643197258e-11:ZNF428::ZNF428:NM_182498.4:VUS:2L0ThiscnvpartiallyoverlapstheZNF428genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
19	46634080	.	N	<DUP>	.	.	Type=Gain;Targets=3;Samples2=1;Span=15801;GeneNames=DACT3,GNG8;GeneIDs=94235,147906;Aliases=HG3E;Genes=2;TranscriptNameClinicallyRelevant=NM_145056.3,NM_033258.2;OverlappingExonsClinicallyRelevant=4,All;HGVSg=NC_000019.10:g.46634080_46649880dup;HGVScClinicallyRelevant=NM_145056.3:c.500-8_1890dup,NM_033258.2:c.1_209dup;HGVSpClinicallyRelevant=.,NP_150283.1:p.*71Cfs;ISCNCytobandNotation=dup(19)q13.32;SequenceOntologyClinicallyRelevant=transcript_ablation,frameshift_variant;RegionClinicallyRelevant=exon,exon;END=46649880	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:119.501:3.03501:1.3547:4.94522959979949e-07:DACT3,GNG8::DACT3:NM_145056.3:VUS:2L0ThiscnvpartiallyoverlapstheDACT3genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
19	47681966	.	N	<DUP>	.	.	Type=Gain;Targets=4;Samples2=1;Span=13514;GeneNames=BICRA;GeneIDs=29998;Aliases=CSS12,GLTSCR1,SMARCK1;Genes=1;TranscriptNameClinicallyRelevant=NM_015711.3;OverlappingExonsClinicallyRelevant=7-10;HGVSg=NC_000019.10:g.47681966_47695479dup;HGVScClinicallyRelevant=NM_015711.3:c.2107-10_3186+5dup;HGVSpClinicallyRelevant=NP_056526.3:p.E703_Q1062dup;ISCNCytobandNotation=dup(19)q13.33;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=47695479	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:105.157:3.1996:1.29983:8.7954100365508e-10:BICRA::BICRA:NM_015711.3:VUS:2L0ThiscnvpartiallyoverlapstheBICRAgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
19	50316025	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=1;Span=4334;GeneNames=KCNC3;GeneIDs=3748;Aliases=KSHIIID,KV3.3,SCA13;Genes=1;TranscriptNameClinicallyRelevant=NM_004977.3;OverlappingExonsClinicallyRelevant=4-5;HGVSg=NC_000019.10:g.50316025_50320358dup;HGVScClinicallyRelevant=NM_004977.3:c.2171-9_2274dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(19)q13.33;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=50320358	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:103.062:5.70558:1.93936:8.84873712233066e-15:KCNC3::KCNC3:NM_004977.3:VUS:2L0ThiscnvpartiallyoverlapstheKCNC3genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
19	50482144	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=1;Span=590;GeneNames=EMC10;GeneIDs=284361;Aliases=C19orf63,HSM1,HSS1,NEDDFAS;Genes=1;TranscriptNameClinicallyRelevant=NM_206538.4;OverlappingExonsClinicallyRelevant=7;HGVSg=NC_000019.10:g.50482144_50482733dup;HGVScClinicallyRelevant=NM_206538.4:c.679-5_789dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(19)q13.33;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=50482733	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:62.4074:2.84892:1.43877:0.000121620288877007:EMC10::EMC10:NM_206538.4:VUS:2L0ThiscnvpartiallyoverlapstheEMC10genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
19	54278763	.	N	<DUP>	.	.	Type=Gain;Targets=5;Samples2=1;Span=1750;GeneNames=LILRB2;GeneIDs=10288;Aliases=CD85D,ILT-4,ILT4,LIR-2,LIR2,MIR-10,MIR10;Genes=1;TranscriptNameClinicallyRelevant=NM_001080978.4;OverlappingExonsClinicallyRelevant=2-6;HGVSg=NC_000019.10:g.54278763_54280512dup;HGVScClinicallyRelevant=NM_001080978.4:c.1_955+49dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(19)q13.42;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=54280512	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:360.463:4.22942:1.4422:1.06279335409925e-19:LILRB2::LILRB2:NM_001080978.4:VUS:2L0ThiscnvpartiallyoverlapstheLILRB2genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
19	54574729	.	N	<DUP>	.	.	Type=Gain;Targets=9;Samples2=1;Span=20253;GeneNames=LILRA1,LILRA2;GeneIDs=11027,11024;Aliases=CD85H,ILT1,LIR-7,LIR7;Genes=2;TranscriptNameClinicallyRelevant=NM_006863.4,NM_001130917.3;OverlappingExonsClinicallyRelevant=1-4,4-8;HGVSg=NC_000019.10:g.54574729_54594981dup;HGVScClinicallyRelevant=NM_006863.4:c.1_358+29dup,NM_001130917.3:c.353-2_1452dup;HGVSpClinicallyRelevant=.,.;ISCNCytobandNotation=dup(19)q13.42;SequenceOntologyClinicallyRelevant=transcript_ablation,transcript_ablation;RegionClinicallyRelevant=exon,exon;Region=19:54556007-54607002;Span2=50996;OverlapType=Within Region;Name=gssvG19391;Frequency=0.0011;Type2=Gain;END=54594981	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:296.084:2.73763:1.29005:3.64713594216031e-15:LILRA1,LILRA2::LILRA1:NM_006863.4:VUS:2L0ThiscnvpartiallyoverlapstheLILRA1genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
19	54829350	.	N	<DUP>	.	.	Type=Gain;Targets=8;Samples2=45;Span=13637;GeneNames=KIR2DS4,KIR3DL1;GeneIDs=3811,3809;Aliases=CD158E1,KIR,KIR2DL5B,KIR3DL1/S1,NKAT-3,NKAT3,NKB1,NKB1B;Genes=2;TranscriptNameClinicallyRelevant=NM_001281971.2,NM_013289.3;OverlappingExonsClinicallyRelevant=1-5,7-9;HGVSg=NC_000019.10:g.54829350_54842986dup;HGVScClinicallyRelevant=NM_001281971.2:c.1_693+68dup,NM_013289.3:c.1001-11_1335dup;HGVSpClinicallyRelevant=.,.;ISCNCytobandNotation=dup(19)q13.42;SequenceOntologyClinicallyRelevant=transcript_ablation,transcript_ablation;RegionClinicallyRelevant=exon,exon;Region=19:54817797-54848660;Span2=30864;OverlapType=Within Region;Name=gssvG19438;Frequency=0.0068;Type2=Gain;END=54842986	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:208.037:1.32317:1.50615:0.000400617556837057:KIR2DS4,KIR3DL1::KIR2DS4:NM_001281971.2:Benign:2L0ThiscnvpartiallyoverlapstheKIR2DS4genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
19	55488959	.	N	<DUP>	.	.	Type=Gain;Targets=4;Samples2=1;Span=1454;GeneNames=SSC5D;GeneIDs=284297;Aliases=S5D-SRCRB;Genes=1;TranscriptNameClinicallyRelevant=NM_001144950.2;OverlappingExonsClinicallyRelevant=2-5;HGVSg=NC_000019.10:g.55488959_55490412dup;HGVScClinicallyRelevant=NM_001144950.2:c.26-47_586+4dup;HGVSpClinicallyRelevant=NP_001138422.1:p.A9_Q195dup;ISCNCytobandNotation=dup(19)q13.42;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=55490412	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:121.497:2.88492:1.31398:3.37895006554493e-08:SSC5D::SSC5D:NM_001144950.2:VUS:2L0ThiscnvpartiallyoverlapstheSSC5Dgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
21	43075743	.	N	<DEL>	.	.	Type=Loss;Targets=5;Samples2=6;Span=31790;GeneNames=CBS,U2AF1;GeneIDs=875,7307;Aliases=CBSL,HIP4;Genes=2;TranscriptNameClinicallyRelevant=NM_000071.3,NM_006758.3;OverlappingExonsClinicallyRelevant=1,All;HGVSg=NC_000021.9:g.43075743_43107532del;HGVScClinicallyRelevant=.,.;HGVSpClinicallyRelevant=.,.;ISCNCytobandNotation=del(21)q22.3;SequenceOntologyClinicallyRelevant=.,.;RegionClinicallyRelevant=.,.;END=43107532	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Deletion:0:-2.30013:0:6.12938531458085e-07:CBS,U2AF1::.:.:VUS:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps2proteincodinggenes:0
22	22888014	.	N	<DUP>	.	.	Type=Gain;Targets=6;Samples2=1;Span=13320;GeneNames=IGLL5;GeneIDs=100423062;Aliases=IGLV,VL-MAR;Genes=1;TranscriptNameClinicallyRelevant=NM_001178126.2;OverlappingExonsClinicallyRelevant=All;HGVSg=NC_000022.11:g.22888014_22901333dup;HGVScClinicallyRelevant=.;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(22)q11.22;SequenceOntologyClinicallyRelevant=.;RegionClinicallyRelevant=.;Region=22:22888723-22906876;Span2=18154;OverlapType=Partial Overlap;Name=gssvG24302;Frequency=0.0645;Type2=Gain;Region2=22:22873170-22898313,22:22895819-22901562;Span3=25144,5744;OverlapType2=Partial Overlap,Partial Overlap;Type3=Duplication,Duplication;Frequency2=0.025,0.00118343;DeletionFrequency=0,0;DuplicationFrequency=0.025,0.00118343;END=22901333	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:261.029:2.40507:1.36277:1.79789608942349e-08:IGLL5::.:.:Benign:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps1proteincodinggenes,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
22	42126475	.	N	<DUP>	.	.	Type=Gain;Targets=12;Samples2=1;Span=14931;GeneNames=CYP2D6,CYP2D7;GeneIDs=1565,1564;Aliases=CPD6,CYP2D,CYP2D7AP,CYP2D7BP,CYP2D7P2,CYP2D8P2,CYP2DL1,CYPIID6,P450-DB1,P450C2D,P450DB1;Genes=2;TranscriptNameClinicallyRelevant=NM_000106.6,NR_145674.3;OverlappingExonsClinicallyRelevant=All,7-9;HGVSg=NC_000022.11:g.42126475_42141405dup;HGVScClinicallyRelevant=.,.;HGVSpClinicallyRelevant=.,.;ISCNCytobandNotation=dup(22)q13.2;SequenceOntologyClinicallyRelevant=.,.;RegionClinicallyRelevant=.,.;Region=22:42118886-42154516,22:42124870-42138033;Span2=35631,13164;OverlapType=Within Region,Partial Overlap;Name=gssvG24663,gssvG24665;Frequency=0.0142,0.2232;Type2=Gain,Gain;END=42141405	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:176.899:1.70312:1.41217:1.89731285113511e-08:CYP2D6,CYP2D7::.:.:Benign:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps1proteincodinggenes,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
